XM tidak memberikan layanan kepada penduduk Amerika Serikat.
F
F

Fresenius


Berita

FDA Says Fresenius Kabi USA Removes Certain Ivenix Large Volume Pump Primary Administration Sets

BRIEF-FDA Says Fresenius Kabi USA Removes Certain Ivenix Large Volume Pump Primary Administration Sets Sept 16 (Reuters) - FDA: FDA: INFUSION PUMP ADMINISTRATION SET RECALL, FRESENIUS KABI USA REMOVES CERTAIN IVENIX LARGE VOLUME PUMP PRIMARY ADMINISTRATION SETS FDA: FDA IDENTIFIED FRESENIUS KABI USA'S CERTAIN IVENIX LARGE VOLUME PUMP PRIMARY ADMINI
F

Top of the Street: Roche, Fresenius, BASF, AstraZeneca, Rational, PSP Swiss Property, Swiss Prime Site

BUZZ-Top of the Street: Roche, Fresenius, BASF, AstraZeneca, Rational, PSP Swiss Property, Swiss Prime Site A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank cuts Roche ROG.S to "sell" from "buy", citing limited catalyst due to a risk of Roche creating a lot of sunk cost for little ultimate return ** J.P.Morgan upgrades Fresenius FREG.DE to "overweight" from "neutral" as it sees earnings compression at the German healthcare group coming to an
A
B
F
J
R
R
S
P
F

Alstom, Siemens, Tesco

EUROPE RESEARCH ROUNDUP-Alstom, Siemens, Tesco Sept 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alstom, Siemens and Tesco, on Friday. HIGHLIGHTS * Alstom ALSO.PA : HSBC raises target price to EUR 26 from EUR 24 * Hexagon AB HEXAB.ST : HSBC cuts target price to SEK 110 from SEK 120 * Siemens AG SIEGN.DE : HSBC cuts target price to EUR 140 from EUR 150 * Tesco TSCO.L : Citigroup raises target price to 425p from 350p * Travis P
A
A
A
B
B
B
C
C
C
D
D
E
E
F
H
H
I
K
L
L
S
S
S
S
T
T
P
A
A
F
S
U

'Medicine is starting to work', JPM upgrades Fresenius

BUZZ-'Medicine is starting to work', JPM upgrades Fresenius ** J.P.Morgan upgrades Fresenius FREG.DE to "overweight" from "neutral" as it sees earnings compression at the German healthcare group coming to an end ** The broker says Fresenius delivered results above expectations in each of the last four quarters and management made progress in improv
F
F

Fresenius Divests IV Manufacturing Site In Chile

BRIEF-Fresenius Divests IV Manufacturing Site In Chile Sept 2 (Reuters) - FRESENIUS SE & CO KGAA FREG.DE : DIVESTS IV MANUFACTURING SITE IN CHILE THIS DIVESTMENT INCLUDES IV LABORATORIO SANDERSON PLANT IN SANTIAGO DE CHILE WILL CONTINUE MANUFACTURING OF EXISTING PORTFOLIO OF PRODUCTS IN CHILE FRESENIUS KABI REMAINS COMMITTED TO CHILEAN AS WELL AS S
F

Adyen NV, Beazley, Nel ASA

EUROPE RESEARCH ROUNDUP-Adyen NV, Beazley, Nel ASA Aug 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen NV, Beazley and Nel ASA, on Friday. HIGHLIGHTS * Adyen NV ADYEN.AS : TD Cowen raises target price to EUR 1,620 from EUR 1,618 * Beazley BEZG.L : HSBC raises target price to 780p from 665p * Diageo DGE.L : HSBC cuts target price to 3,000p from 3,300p * Nel ASA NEL.OL : Berenberg cuts to hold from buy * ThyssenKrupp Nucera
A
A
B
B
B
C
C
D
D
E
F
F
G
H
I
L
P
P
S
T
V
D
D
F

Danske Bank, Greggs, HSBC

EUROPE RESEARCH ROUNDUP-Danske Bank, Greggs, HSBC Aug 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Danske Bank, Greggs, and HSBC, on Thursday. HIGHLIGHTS * Danske Bank DANSKE.CO : HSBC raises target price to DKK 258 from DKK 257 * Greggs GRG.L : Berenberg raises target price to 3600p from 3340p * HSBC HSBA.L : Berenberg raises target price to 870p from 830p * Kardex Holding AG KARN.S : Berenberg raises target price to CHF 260
A
A
A
A
A
B
B
C
C
C
D
F
G
G
H
L
T
W
A
D
S

Fresenius beats Q2 view on strong unit performance, cost savings

UPDATE 2-Fresenius beats Q2 view on strong unit performance, cost savings Adds details on restructuring in paragraphs 5, 6, profit for units in paragraph 7 By Bartosz Dabrowski July 31 (Reuters) - German healthcare group Fresenius FREG.DE beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and Helios units, and progress in group-wide cost savings.
F
F

Fresenius beats Q2 expectations on strong unit performance, cost savings

Fresenius beats Q2 expectations on strong unit performance, cost savings July 31 (Reuters) - German healthcare group Fresenius FREG.DE beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and Helios units, and progress in group-wide cost savings. It reported earnings before interests and taxes (EBIT) of 660 million euros ($714 million), up 16% from a year ago.
F
F

Dialysis firm FMC cuts outlook for US treatment volumes, shares fall

UPDATE 1-Dialysis firm FMC cuts outlook for US treatment volumes, shares fall Recasts with US patient volumes outlook, adds shares in paragraph 4 July 30 (Reuters) - World's largest dialysis specialist Fresenius Medical Care FMEG.DE cut the outlook for volumes in its key U.S. market on Tuesday after revenue from treatments there fell in the second quarter, weighed down by elevated mortality due to COVID-19 and flu among its patients.
F
F

Dialysis specialist FMC's Q2 profit meets expectations

Dialysis specialist FMC's Q2 profit meets expectations July 30 (Reuters) - World's largest dialysis specialist Fresenius Medical Care FMEG.DE reported adjusted second-quarter operating profit in line with expectations on Tuesday. Robust earnings in its health care products division, which produces dialysis machines, helped offset weaker patient volumes in the main health care services division, which provides dialysis procedures.
F
F

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead July 26 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 30-Jul-2024 NTS 1COV.DE Covestro AG Half Year 2024 Covestro AG Earnings Release 30-Jul-2024 BMO HEIG.DE Heidelberg Materials AG Half Year 2024 Heidelberg Materials AG Earnings Release 30-Jul-2024 04:30 AIR.PA Airbus SE Half Year 2024 Airbus SE Earnings Release 31-Jul-2024 AMC QGEN.N Qiagen NV Q2 20
A
A
B
F
M
P
S
S
V
V
Q
G

MS raises Fresenius to 'overweight' on 'tipping point on portfolio simplification'

BUZZ-MS raises Fresenius to 'overweight' on 'tipping point on portfolio simplification' ** Morgan Stanley raises Fresenius FREG.DE to "overweight" from "equal weight," as it sees the German healthcare group has "reached a tipping point on portfolio simplification" ** The analyst says that Kabi, the company's division for IV drugs, nutrition product
F
F

Anglo American, Rio Tinto, Unilever

EUROPE RESEARCH ROUNDUP-Anglo American, Rio Tinto, Unilever July 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anglo American, Rio Tinto and Unilever, on Tuesday. HIGHLIGHTS * Anglo American Plc AAL.L : HSBC cuts target price to 2,300p from 2,450p * Antofagasta Plc ANTO.L : HSBC raises target price to 1,400p from 1,100p * Belimo Holding AG BEAN.S : Jefferies raises target price to CHF 598 from CHF 498 * Rio Tinto RIO.L : HSBC
A
A
A
B
B
D
E
F
G
G
G
P
T
W
A
A
B
G
R

Fresenius SE: Announces EMA Acceptance For Review Of Denosumab Biosimilar Candidates

BRIEF-Fresenius SE: Announces EMA Acceptance For Review Of Denosumab Biosimilar Candidates July 11 (Reuters) - Fresenius SE & Co KGaA FREG.DE : ANNOUNCES EMA ACCEPTANCE FOR REVIEW OF DENOSUMAB BIOSIMILAR CANDIDATES Further company coverage: FREG.DE Reporting by Berlin Newsroom
F



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.